Adam Gazzaley

Adam Gazzaley is the David Dolby Distinguished Professor of Neurology, Physiology, and Psychiatry at the University of California, San Francisco (UCSF) School of Medicine, where he serves as Founder & Executive Director of Neuroscape, a translational neuroscience center. His work bridges cognitive neuroscience, technology development, and clinical applications.

His research focuses on cognitive control mechanisms, neuroplasticity, and technology-driven interventions for cognitive disorders. Key areas include attention, memory, aging, and the development of closed-loop video games integrated with VR/AR, physiological monitoring, and brain stimulation. Recent work explores psychedelic neuroscience in aging populations and digital therapeutics for multiple sclerosis.

Notable trends across his 160+ publications show increasing focus on digital biomarkers, personalized cognitive training, and translational applications of neuroplasticity principles. His work spans basic neuroscience (fMRI/EEG/TMS methodologies) to clinical implementation (FDA-cleared digital therapeutics).

• 2015 SfN Science Educator Award
• 2020 Global Gaming Citizen Honor
• Newsweek's 2021 America’s Greatest Disruptors
• 2017 PROSE Award for The Distracted Mind

As Chief Science Advisor of Akili Interactive and co-founder of JAZZ Venture Partners, he translates research into commercial applications. He has advised Apple, GE, Nielsen, Deloitte, and Magic Leap, and served on the President's Council on Fitness, Sports & Nutrition. His Neuroscape lab develops open-source cognitive assessment tools while advancing rigorous placebo-controlled trials of digital interventions.